BELTSVILLE, Md., April 05, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12th at… Read More..

MARCH 31, 2022 ENDED WITH TOTAL MEMBERS REACHING A RECORD 2.23 MILLION** 1.48 MILLION** TOTAL PAID MEMBERS 750,000 TOTAL FREE MEMBERS LiveOne Maintains Guidance to Achieve Positive Adjusted EBITDA* in Q1 FY 2023 Ending June 30, 2022; Maintains Revenue Guidance for FY 2023 of Between $125 - $140 Million and… Read More..

ANN ARBOR, MI / ACCESSWIRE / April 4, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced the commercial launch of its newest assay - endogenous ACTH (eACTH) - for the TRUFORMA In-Clinic Biosensor Testing… Read More..